Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Acute beta-blockade prevents myocardial beta-adrenergic receptor desensitization and preserves early ventricular function after brain death.

Pandalai PK, McLean KM, Bulcao CF, Duffy JY, D'Souza KM, Merrill WH, Pearl JM, Akhter SA.

J Thorac Cardiovasc Surg. 2008 Apr;135(4):792-8. doi: 10.1016/j.jtcvs.2007.09.038.

2.

Effects of beta-blockade on beta-adrenergic receptors and signal transduction.

Karliner JS.

J Cardiovasc Pharmacol. 1989;14 Suppl 5:S6-12. Review.

PMID:
2478812
3.

The beta-adrenergic receptor-adenylate cyclase complex as a target for therapeutic intervention in heart failure.

Bristow MR, Port JD, Hershberger RE, Gilbert EM, Feldman AM.

Eur Heart J. 1989 Jun;10 Suppl B:45-54. Review.

PMID:
2572420
4.

Sensitization of the beta-adrenergic system in acute myocardial ischaemia by a protein kinase C-dependent mechanism.

Strasser RH, Marquetant R.

Eur Heart J. 1991 Dec;12 Suppl F:48-53. Review.

PMID:
1666555
5.

Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization.

Hata JA, Williams ML, Koch WJ.

J Mol Cell Cardiol. 2004 Jul;37(1):11-21. Review.

PMID:
15242731
6.

beta-adrenergic mechanisms in cardiac diseases: a perspective.

Chakraborti S, Chakraborti T, Shaw G.

Cell Signal. 2000 Aug;12(8):499-513. Review.

PMID:
11027943
7.

Molecular restoration of beta-adrenergic receptor signaling improves contractile function of failing hearts.

Tevaearai HT, Koch WJ.

Trends Cardiovasc Med. 2004 Aug;14(6):252-6. Review.

PMID:
15451518
8.

The beta-adrenergic receptor. Configuration, regulation, mechanism of action.

Bristow MR.

Postgrad Med. 1988 Feb 29;Spec No:19-26. Review.

PMID:
2894659
9.

Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.

Osadchii OE.

Heart Fail Rev. 2007 Mar;12(1):66-86. Epub 2007 Mar 27. Review.

PMID:
17387610
10.

What is the role of beta-adrenergic signaling in heart failure?

Lohse MJ, Engelhardt S, Eschenhagen T.

Circ Res. 2003 Nov 14;93(10):896-906. Review.

11.

Role of G-protein-coupled receptor kinase 2 in the heart--do regulatory mechanisms open novel therapeutic perspectives?

Hansen JL, Theilade J, Aplin M, Sheikh SP.

Trends Cardiovasc Med. 2006 Jul;16(5):169-77. Review.

PMID:
16781951
12.

The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation.

Bassiakou E, Xanthos T, Papadimitriou L.

Eur J Pharmacol. 2009 Aug 15;616(1-3):1-6. doi: 10.1016/j.ejphar.2009.06.019. Epub 2009 Jun 23. Review.

PMID:
19555681
13.

An overview of beta-adrenoceptors and signal transduction--desensitization in cardiac disease and effect of beta-blockade.

Fu LX, Waagstein F, Hjalmarson A.

Int J Cardiol. 1991 Mar;30(3):261-8. Review. No abstract available.

PMID:
1676018
14.

CNS adrenergic receptors and beta blockade.

Mann JJ, Arango V.

Postgrad Med. 1988 Feb 29;Spec No:135-9. Review.

PMID:
2894655
15.

Methods for the detection of altered beta-adrenergic receptor signaling pathways in hypertrophied hearts.

Wolf MJ, Tachibana H, Rockman HA.

Methods Mol Med. 2005;112:353-62. Review.

PMID:
16010029
16.

Alterations in adrenergic receptor signaling in heart failure.

Lamba S, Abraham WT.

Heart Fail Rev. 2000 Mar;5(1):7-16. Review.

PMID:
16228912
17.

[Pathophysiology of chronic heart failure].

Weil J, Schunkert H.

Clin Res Cardiol. 2006;95 Suppl 4:1-15; quiz 16-7. Review. German.

PMID:
16598604
18.

Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone.

Boldt J, Suttner S.

Expert Opin Pharmacother. 2007 Sep;8(13):2135-47. Review.

PMID:
17714066
19.
20.

Regulation of coronary blood flow during exercise.

Duncker DJ, Bache RJ.

Physiol Rev. 2008 Jul;88(3):1009-86. doi: 10.1152/physrev.00045.2006. Review.

Supplemental Content

Support Center